Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;27(19):2819-2840.
doi: 10.1111/jcmm.17913. Epub 2023 Aug 22.

Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings

Affiliations
Review

Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings

Nabarun Chandra Das et al. J Cell Mol Med. 2023 Oct.

Abstract

More than half a century has passed since the introduction of the National Filariasis Control Program; however, as of 2023, lymphatic filariasis (LF) still prevails globally, particularly in the tropical and subtropical regions, posing a substantial challenge to the objective of worldwide elimination. LF is affecting human beings and its economically important livestock leading to a crucial contributor to morbidities and disabilities. The current scenario has been blowing up alarms of attention to develop potent therapeutics and strategies having efficiency against the adult stage of filarial nematodes. In this context, the exploration of a suitable drug target that ensures lethality to macro and microfilariae is now our first goal to achieve. Apoptosis has been the potential target across all three stages of filarial nematodes viz. oocytes, microfilariae (mf) and adults resulting in filarial death after receiving the signal from the reactive oxygen species (ROS) and executed through intrinsic and extrinsic pathways. Hence, it is considered a leading target for developing antifilarial drugs. Herein, we have shown the efficacy of several natural and synthetic compounds/nanoformulations in triggering the apoptotic death of filarial parasites with little or no toxicity to the host body system.

Keywords: ROS; apoptosis; drug development; filariasis; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Schematic representation of the potential efficacy of different chemotherapeutics across the developmental stages of filarial parasites reside in the human host (Wuchereria bancrofti and Onchocerca volvulus), bovine host (Setaria cervi) and rodent host (Acanthocheilonema viteae).
FIGURE 2
FIGURE 2
Mechanism of apoptosis in filarial parasites. ROS‐induced oxidative stress within the filarial parasites activates a major cell death pathway. EGL‐1 the apoptosis inducer disrupts the normal CED‐4–CED‐9 complex form and makes an association with CED‐9 to create a pro‐apoptotic moiety. Free CED‐4 dimers then oligomerize and make tetrameric apoptosomes with proCED‐3. Activated and cleaved CED‐3 is the ultimate protein responsible for apoptosis in filaria parasites.
FIGURE 3
FIGURE 3
Apoptosis as a target for developing antifilarial drugs. Apoptosis‐inducing drugs primarily raise oxidative stress inside the parasite body and subsequently activate intrinsic, extrinsic as well as filarial conserved apoptosis pathways, EGL‐1/CED‐9/CED‐4/CED‐3 pathway.
FIGURE 4
FIGURE 4
Apoptosis as an efficacious target in developing antifilarials in comparison to conventional drug targets.

Similar articles

Cited by

References

    1. Mukherjee S, Joardar N, Babu SPS. Redox regulatory circuits as targets for therapeutic intervention of bancroftian filariasis: biochemical, molecular, and pharmacological perspectives. Oxidative Stress in Microbial Diseases. Springer; 2019:185‐208.
    1. Famakinde DO. Mosquitoes and the lymphatic filarial parasites: research trends and budding roadmaps to future disease eradication. Trop Med Infect Dis. 2018;3(1):4. - PMC - PubMed
    1. Shenoy RK. Clinical and pathological aspects of filarial lymphedema and its management. Korean J Parasitol. 2008;46(3):119‐125. - PMC - PubMed
    1. Partono F. The spectrum of disease in lymphatic filariasis. Ciba Found Symp. 1987;127:15‐31. - PubMed
    1. Mukherjee S, Karmakar S, Babu SPS. TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review. Brazilian J Infect Dis. 2016;20(2):193‐204. - PMC - PubMed

Publication types

Substances